Trial intelligence / Profile preview

ED-INNOVATION: SL-BUP vs XR-BUP for Opioid Use Disorder

NCT04225598Phase 2Completed

Sponsor
Yale University
Start
Jul 2020
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of CAM2038 in opioid use disorder (OUD), sponsored by Yale University. Started Jul 2020; status: completed.

02

Drugs

CAM2038
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT04225598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04225598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call